LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=m88edab33616ad61649dcd528fd17dd3b

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Upon completion of this activity, the learners should be able to formulate the best course of Urology Cancer treatment for the patient with the input of the tumor board team, (2) Identify appropriate NCCN guidelines-based care for patients with primary renal/prostate cancer, as well as metastatic disease. 

PLANNER/MODERATOR DISCLOSURE: Scott Webster, MD, was a speaker for Astellas Pharma Inc.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Lidya Gebresellassie at [email protected]